Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Deep End Partners is a venture capital firm founded in 2020 and based in New York City. The firm focuses on seed and early-stage investments, primarily within the psychedelic and mental health sectors. Deep End Partners aims to support innovative companies that are shaping the future of mental health treatment, particularly in life sciences and healthtech.
Currently, the firm has a small team consisting of one partner and manages a portfolio of approximately six companies. Deep End Partners has made a notable exit with ATAI Life Sciences, which went public on NASDAQ. The firm primarily invests in US-based companies, reflecting its commitment to the domestic market.
Deep End Partners specializes in seed and early-stage investments, particularly in the psychedelic and mental health ecosystem. The firm adopts a minority investment approach, focusing on life sciences and healthtech sectors. This investment strategy allows Deep End Partners to engage with innovative startups that are developing new treatments and therapies in mental health.
The firm looks for companies that are pioneering advancements in psychedelic pharmaceuticals and related health technologies. Deep End Partners seeks to partner with founders who are passionate about transforming mental health treatment and are equipped to navigate the complexities of this emerging field.
Deep End Partners has a portfolio of approximately six companies, with a notable exit being ATAI Life Sciences, a German-listed psychedelic pharmaceutical company that went public on NASDAQ. This exit highlights the firm's focus on companies that are at the forefront of mental health innovation.
While specific details about the remaining portfolio companies are not disclosed, the firm’s emphasis on the psychedelic and mental health sectors suggests that its investments are aligned with groundbreaking advancements in these fields.
Unknown Partner - Deep End Partners operates with a very small team, currently identified as having one partner. Specific details about this individual, including their background and expertise, are not publicly available.
Deep End Partners has made a notable exit with ATAI Life Sciences, which went public on NASDAQ. This exit marks a significant milestone for the firm since its founding in 2020.
As of now, there are no recent announcements or updates regarding new investments or changes within the firm.
What are Deep End Partners' investment criteria?
Deep End Partners invests in seed and early-stage companies, particularly within the psychedelic and mental health sectors. The firm focuses on life sciences and healthtech, adopting a minority investment approach.
How can founders apply or pitch to Deep End Partners?
Founders interested in pitching to Deep End Partners should prepare a detailed presentation that outlines their business model, market opportunity, and how their company aligns with the firm’s focus on mental health and psychedelics.
What makes Deep End Partners different from other venture capital firms?
Deep End Partners specializes in the psychedelic and mental health sectors, which are rapidly evolving fields. The firm’s expertise in these areas allows it to provide unique insights and support to its portfolio companies.
What is the geographic scope of Deep End Partners' investments?
The firm primarily invests in US-based companies, reflecting its commitment to the domestic market and the potential for growth in the local ecosystem.
What is the typical check size for investments made by Deep End Partners?
Specific check sizes are not publicly disclosed, but the firm focuses on seed and early-stage investments, which typically involve smaller initial funding rounds.
What kind of post-investment involvement can portfolio companies expect?
Deep End Partners provides strategic support and resources to its portfolio companies, leveraging its expertise in the psychedelic and mental health sectors to help them navigate challenges and capitalize on opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.